1. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling
    Xiaofeng Zhao et al, 2017, Oncotarget CrossRef
  2. The potential and controversy of targeting STAT family members in cancer
    Yannick Verhoeven et al, 2020, Seminars in Cancer Biology CrossRef
  3. Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells
    Guangming Zhao et al, 2017, Oncology Reports CrossRef
  4. miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3
    Shu Liu et al, 2016, Oncology Reports CrossRef
  5. Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
    Zhiqiang Guo et al, 2017, Oncotarget CrossRef
  6. α-Mangostin and Apigenin Induced Cell Cycle Arrest and Programmed Cell Death in SKOV-3 Ovarian Cancer Cells
    Teeranai Ittiudomrak et al, 2019, Toxicological Research CrossRef
  7. Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells
    Yefang Xu et al, 2015, International Journal of Gynecologic Cancer CrossRef
  8. Quercetin Induces Apoptosis in Glioblastoma Cells by Suppressing Axl/IL-6/STAT3 Signaling Pathway
    Hyo In Kim et al, 2021, The American Journal of Chinese Medicine CrossRef
  9. Metabolic Variations of Flavonoids in Leaves of T. media and T. mairei Obtained by UPLC-ESI-MS/MS
    Tao Wang et al, 2019, Molecules CrossRef
  10. Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
    Shunyu Hou et al, 2018, PLOS ONE CrossRef
  11. Apigenin: A dietary flavonoid with diverse anticancer properties
    Josip Madunić et al, 2018, Cancer Letters CrossRef
  12. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
    Sherri Smart et al, 2018, Cancers CrossRef
  13. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma
    Saeideh Momtaz et al, 2017, BioFactors CrossRef
  14. Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma
    Joo Hyun Kim et al, 2019, BMC Cancer CrossRef
  15. MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL
    Rui Li et al, 2015, Tumor Biology CrossRef
  16. Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells
    Wei-Chien Huang et al, 2016, Oncotarget CrossRef
  17. Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
    Susan R. Mallery et al, 2017, Cancer Prevention Research CrossRef
  18. Investigation of possible effects of apigenin, sorafenib and combined applications on apoptosis and cell cycle in hepatocellular cancer cells
    Nazlı Şirin et al, 2020, Gene CrossRef
  19. Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer
    Matteo Santoni et al, 2015, Expert Opinion on Investigational Drugs CrossRef
  20. Ginsenoside 3β-O-Glc-DM (C3DM) enhances the antitumor activity of Taxol on Lewis lung cancer by targeting the interleukin-6/Jak2/STAT3 and interleukin-6/AKT signaling pathways
    Yan Li et al, 2020, World Journal of Traditional Chinese Medicine CrossRef
  21. Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
    Tatyana Novoyatleva et al, 2021, Communications Biology CrossRef
  22. Health functionality of apigenin: A review
    Fahad Ali et al, 2017, International Journal of Food Properties CrossRef
  23. Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP-9
    Xin-Jun Chen et al, 2016, Molecular Medicine Reports CrossRef
  24. Flavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor
    Benjamin M. Hariri et al, 2017, Journal of Biological Chemistry CrossRef
  25. Gene of the month: Axl
    Matthew Brown et al, 2016, Journal of Clinical Pathology CrossRef
  26. Apigenin: A natural bioactive flavone-type molecule with promising therapeutic function
    Dharambir Kashyap et al, 2018, Journal of Functional Foods CrossRef
  27. Jak/STAT Signaling in Head and Neck Cancer
    Elizabeth Cedars et al, 2018, Molecular Determinants of Head and Neck Cancer CrossRef
  28. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma
    Doo-Sik Kong et al, 2016, Oncotarget CrossRef
  29. Epigenetic inhibition of the tumor suppressor ARHI by light at night‐induced circadian melatonin disruption mediates STAT3‐driven paclitaxel resistance in breast cancer
    Shulin Xiang et al, 2019, Journal of Pineal Research CrossRef
  30. TAM family proteins and therapy resistance
    Nellie K. McDaniel et al, 2020, Improving the Therapeutic Ratio in Head and Neck Cancer CrossRef
  31. The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
    Magdalena Paolino et al, 2016, Cancers CrossRef
  32. Rationalizing the therapeutic potential of apigenin against cancer
    Semim Akhtar Ahmed et al, 2021, Life Sciences CrossRef
  33. Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks
    Deepti Singh et al, 2020, Recent Patents on Anti-Cancer Drug Discovery CrossRef
  34. Plant Flavone Apigenin: an Emerging Anticancer Agent
    Eswar Shankar et al, 2017, Current Pharmacology Reports CrossRef
  35. Targeting the IL-6/JAK/STAT3 signalling axis in cancer
    Daniel E. Johnson et al, 2018, Nature Reviews Clinical Oncology CrossRef
  36. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
    Chanitra Thuwajit et al, 2018, Medicinal Research Reviews CrossRef
  37. Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis
    Min Tian et al, 2021, Acta Pharmacologica Sinica CrossRef
  38. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
    Xiaolan Zhu et al, 2017, Oncotarget CrossRef
  39. Metabolite Differences of Polyphenols in Different Litchi Cultivars (Litchi chinensis Sonn.) Based on Extensive Targeted Metabonomics
    Nonghui Jiang et al, 2021, Molecules CrossRef
  40. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
    Luciana Mosca et al, 2021, Drug Resistance Updates CrossRef
  41. Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Tumour Microenvironment
    Derek W. Edwardson et al, 2019, Breast Cancer Metastasis and Drug Resistance CrossRef
  42. Flavonoids Regulate Inflammation and Oxidative Stress in Cancer
    Guangxing Li et al, 2020, Molecules CrossRef
  43. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells
    Nour Al Kafri et al, 2021, Biochemistry and Biophysics Reports CrossRef
  44. Novel Recombinant Protein FlaA N/C Protects against Radiation Injury via NF-κB Signaling
    Ying Xu et al, 2015, Radiation Research CrossRef
  45. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
    Xiaohui Yan et al, 2017, Cell & Bioscience CrossRef
  46. Midkine silencing enhances the anti–prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB
    Suat Erdogan et al, 2020, Investigational New Drugs CrossRef
  47. Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
    Md. Abdul Aziz et al, 2021, Life Sciences CrossRef
  48. The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
    Szulc-Kielbik Izabela et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  49. Novel activators and small-molecule inhibitors of STAT3 in cancer
    Lehe Yang et al, 2019, Cytokine & Growth Factor Reviews CrossRef
  50. Apigenin: A current review on its beneficial biological activities
    Xiang Zhou et al, 2017, Journal of Food Biochemistry CrossRef
  51. pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus
    Katie O’ Sullivan et al, 2018, International Journal of Molecular Sciences CrossRef
  52. A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer
    Chih-Ming Su et al, 2016, Oncotarget CrossRef
  53. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
    Robin Schmitz et al, 2016, Oncotarget CrossRef
  54. Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
    Qingmei Ye et al, 2019, Frontiers in Oncology CrossRef
  55. Apigenin as an anticancer agent
    Muhammad Imran et al, 2020, Phytotherapy Research CrossRef
  56. Phytoestrogens for Cancer Prevention and Treatment
    Margalida Torrens-Mas et al, 2020, Biology CrossRef
  57. Immunotherapies in ovarian cancer
    Elena García-Martínez et al, 2020, European Journal of Cancer Supplements CrossRef
  58. NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway
    Shanyu Fang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef